OLSEN, TW Publications Update 12-7-2016

AUTHORSHIP First Second Senior Other TOTAL

Article 30 8 12 38 88

Case Reports 2 0 2 0 4

Monographs 5 0 0 0 5

Book Chapter 12 2 10 1 25

Other 11 3 1 4 19

TOTAL 60 13 25 43 141

PEER REVIEWED LITERATURE 1. Olsen TW, Pulido JS, Folk JC, Hyman L, Flaxel CJ, Adelman RA. Retinal and

Ophthalmic Artery Occlusions Preferred Practice Pattern(R). Ophthalmology; e-pub

October, 2016. 2. Shantha JG, Crozier I, Varkey JB, Kraft CS, Lyon GM 3rd, Mehta AK, Carlson RD, Hill

CE, Kumar G, Debiec MR, Patel PS, Olsen TW, Nussenblatt RB, Martin DF, Stroher U, Uyeki TM, Ribner BS, Smith JR, Yeh S. Long-term Management of Panuveitis and Iris Heterochromia in an Ebola Survivor, Ophthalmology; September (e-pub) 2016.

3. Rothschild MI, Russ R, Brennan KA, Williams CJ, Berrones D, Patel B, Martinez-Castellanos MA, Fernandes A, Hubbard GB, Chan RP, Yang Z, Olsen TW. The Economic Model of Retinopathy of Prematurity (EcROP) Screening and Treatment: Mexico and the United States. Am J Ophthalmol, 168: 110-21: 2016.

4. Olsen, TW. Obitiuary: Henry F. Edelhauser, 1937-2015: “A Life with Great Timing,

Skill, and Elegance”. Am J Ophthalmol. March 2016;163:200-201.

5. Feder RS, Olsen TW, Prum BE, Jr., et al. Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern((R)) Guidelines. Ophthalmology 2016;123:P209-36.

6. Folk JC, Adelman RA, Flaxel CJ, Hyman L, Pulido JS, Olsen TW. Idiopathic Epiretinal Membrane and Vitreomacular Traction Preferred Practice Pattern((R)) Guidelines.

Ophthalmology 2016;123:P152-81.

7. Pulido JS, Flaxel CJ, Adelman RA, Hyman L, Folk JC, Olsen TW. Retinal Vein Occlusions Preferred Practice Pattern((R)) Guidelines. Ophthalmology 2016;123:P182-208.

8. Olsen TW, Bottini AR, Mendoza P, Grossniklaus HE. The Age-Related Macular

Degeneration Complex: Linking Epidemiology and Histopathology using the Minnesota Grading System (The Inaugural Frederick C. Blodi Lecture). Trans Am Ophthalmol Soc; 113; 1-9; 2015.

9. Olsen, TW. Invited Editorial: Anti-VEGF Pharmacotherapy as an Alternative to

Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy. JAMA 314:20:2135-6, Nov 24, 2015.

10. Ryan ME, Rajalakshmi R, Prathiba V, Anjana RM, Ranjani H, Narayana V, Olsen TW, Mohan V, Ward LA, Lynn MJ, Hendrick AM. Comparison Among Methods of

Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic Photography. Ophthalmology 2015;122(10):2038-43, October 2015. PMCID:4581972

11. Olsen TW. Suprachoroidal Drug Delivery: Unique New Observations. Invest Ophthalmol

Vis Sci 2015;56(8):4976, July 2015. 12. Allen RS, Olsen TW, Sayeed I, Morrison KC, Oumarbaeva Y, Lucaciu I, Boatright J,

Pardue MT, Stein DG. Progesterone treatment in two rat models of ocular ischemia. Invest Ophthalmol Vis Sci 2015;56(5):2880-91, May 2015. PMCID:26024074

13. Olsen TW*, Palejwala NV, Lee LB, Bergstrom CS, Yeh S. Chorioretinal folds: associated

disorders and a related maculopathy: Reply. Am J Ophthalmol. July 2014;158:409-410.

14. Olsen TW*, Palejwala NV, Lee LB, Bergstrom CS, Yeh S. Chorioretinal folds: associated

disorders and a related maculopathy. Am J Ophthalmol. May 2014;157(5):1038-1047.

15. Ardeljan D, Wang Y, Park S, Shen D, Chu XK, Yu CR, Abu-Asab M, Tuo J, Eberhart CG, Olsen TW, Mullens RF, White G, Wadsworth S, Scaria A, Chan CC: Interleukin-17 Retinotoxicity Is Prevented by Gene Transfer of a Soluble Interleukin-17 Receptor Acting as a Cytokine Blocker: Implications for Age-Related Macular Degeneration. PloS One 2014, 9(4):e95900.

16. Mathai G, Rosen D, Melkote S, Olsen T. Tissue Translocation Device for Surgical

Correction of Age-Related Macular Degeneration. J Med Devices. Dec 2013;7(4).

17. Ho VY, Yeh S, Olsen TW, Bergstrom CS, Yan J, Cribbs BE, Hubbard GB, 3rd. Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors. Am J Ophthalmol. Jul 2013;156(1):23-28 e22.

18. Fortun JA, Grossniklaus HE, Wabner KA, Dou C, Olsen TW, Hubbard GB, 3rd. The effect of air tamponade on the ingress of ocular surface pathogens in sutureless transconjunctival microincisional vitrectomy. Retina. Mar 2013;33(3):566-570.

19. Lee PP, West SK, Block SS, Clayton J, Cotch MF, Flynn C, Geiss LS, Klein R, Olsen TW, Owsley C, Primo SA, Rubin GS, Ryskulova A, Sharma S, Friedman DS, Zhang X, Crews JE, Saaddine JB. Surveillance of Disparities in Vision and Eye Health in the United

States: An Expert Panel's Opinions. Am J Ophthalmol. Dec 2012;154(6 Suppl):S3-7.

20. Dave HB, Gordillo L, Yang Z, Zhang MS, Hubbard GB, 3rd, Olsen TW*. The Societal Burden of Blindness Secondary to Retinopathy of Prematurity in Lima, Peru. Am J Ophthalmol 2012;154:750-755. PMID:22831839

21. Grinager H, Krason D, Olsen TW*. Lyme Disease: Resolution of a Serous Retinal

Detachment and Chorioretinal Folds after Antibiotic Therapy. Retinal Cases and Brief Reports 2012;6:232-234.

22. Jung CS, Payne JF, Bergstrom CS, Cribbs BE, Yan J, Hubbard GB, Olsen TW, Yeh S.

Multimodality diagnostic imaging in unilateral acute idiopathic maculopathy. Arch Ophthalmol 2012;130:50-6.

23. Davis J, Olsen TW, Stewart M, Sternberg P Jr. How the Comparison of Age-related Macular Degeneration Treatments Trial Results Will Impact Clinical Care. Am J Ophthalmol,. 152(4): p. 509-14, October 2011 (lead article).

24. Olsen, TW*, Feng X, Wabner K, Csaky K, Pambuccian S, Cameron JD. Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model. Invest Ophthalmol Vis Sci 2011;52:4749-56; PMCID 3175963, June 2011.

25. Cao X, Shen D, Patel MM, Tuo J, Johnson TM, Olsen TW, Chan CC. Macrophage polarization in the Macula of Age-Related Macular Degeneration: A Pilot Study. Pathology International, doi:10.111/j.1440-1827.2011.02695.x; pp 1-5; May 2011.

26. Olsen TW*, Pribila JT. Pars Plana Vitrectomy with Endoscopic-Guided Sutured Posterior Chamber Intraocular Lens Implantation in Children and Adults. Am J Ophthalmol February 2011;151:2;287-296. (Cover Photograph February Journal obtained from this article).

27. Payne JF, Keenum DG, Sternberg P Jr., Thliveris A, Kala A, Olsen TW*. Concentrated

Intravitreal Amphotericin B in Fungal Endophthalmitis. Arch Ophthalmol Arch Ophthalmol 2010;128:1546-1550.

28. Karunadharma PP, Nordgaard CL, Olsen TW, Ferrington DA. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest Ophthalmol Vis Sci 2010; 51:5470-5479. PMID: 20960615

29. Edelhauser HF, Rowe-Rendleman CL, Robinson MR, Edelhauser HF, Rowe-Rendleman

CL, Robinson MR, Dawson DG, Chader GJ, Grossniklaus HE, Rittenhouse KD, Wilson CG, Weber DA, Kuppermann BD, Csaky KG, Olsen TW, Kompella UB, Holers VM, Hageman GS, Gilger BC, Campochiaro PA, Whitcup SM, Wong WT. Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci 2010; 51:5403-5420. PMID: 20980702.

30. Whitcomb JE, Barnett VA, Olsen TW, Barocas VH. Ex Vivo Porcine Iris Stiffening Due to

Drug Stimulation. Exp Eye Rsch. October 2009; 456-61.

31. Semmer AE, Lee MS, Harrison AR, Olsen TW. Hydroxychloroquine retinopathy screening. Br J Ophthalmol 2008; 92:1653-5.

32. Olsen TW*. The Minnesota Grading System Using Fundus Autofluorescence of Eyebank Eyes: A Correlation to Age-Related Macular Degeneration. Trans Am Ophthalmol Soc

2008; 106:383-401.

33. Tuo J, Ross RJ, Reed GF, Yan Q, Wang JJ, Bojanowski CM, Chew EY, Feng X, Olsen TW, Ferris FL III, Mitchell P, Chan CC. The HtrA1 Promoter Polymorphism, Smoking, and Age-related Macular Degeneration in Multiple Case-control Samples. Ophthalmology, November 2008; 1891-8.

34. Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA. Mitochondrial

proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest Ophthalmol Vis Sci, July 2008; 2848-55.

35. Decanini A, Karunadharma PR, Nordgaard CL, Feng X, Olsen TW, Ferrington DA. Human retinal pigment epithelium proteome changes in early diabetes. Diabetologia, June 2008;51:1051-61

36. Guifang Z, Feng X, Wabner K, Fandrey C, Naqwi A, Wiedmann T, Olsen TW*. Intraocular

Nanoparticle Drug Delivery: A Pilot Study Using an Aerosol during Pars Plana Vitrectomy. Invest Ophthalmol Vis Sci 48 (11): 5243-5249, November, 2007.

37. Olsen TW* Treatment of Exudative Age-related Macular Degeneration: Many Factors to Consider. Editorial by Invitation. Am J. Ophthalmol, 144 (2): 281-83, August 2007.

38. Ethen CM, Reilly C, Feng X, Olsen TW, Ferrington DA. Age-related macular degeneration

and retinal protein modification by 4-hydroxy-2-nonenal. Invest Ophthalmol Vis Sci 48 (8): 3469-3479, August 2007.

39. Schwarzenberg SJ, Thomas W, Olsen TW, et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 30:1056-61; May 2007.

40. Decanini A, Nordgaard CL, Feng X, Ferrington DA, Olsen TW*. Changes in Select Redox Proteins of the Retinal Pigment Epithelium in Age Related Macular Degeneration. Am J

Ophthalmol, 143(4):607-615, April 2007.

41. Ethen CM, Hussong SA, Reilly C, Feng X, Olsen TW, Ferrington DA. Transformation of the Proteosome with Age-related Macular Degeneration. FEBS Lett 581:885-90; Feb. 2007.

42. Olsen TW*, Feng X, Wabner K, Conston SR, Sierra DH, Folden DV, Smith ME, Cameron JD. Cannulation of the Suprachoroidal Space: A Novel Drug Delivery Methodology to the Posterior Segment. Am J Ophthalmol, 142 (5): 777-787, November 2006.

43. Ethen, CM, Reilly C, Feng X, Olsen TW, Ferrington DA. The Proteome of Central and Peripheral Retina with Progression of Age-related Macular Degeneration. Invest Ophthalmol Vis Sci. 47 (6) pp 2280-90, June 2006.

44. Kapphahn RJ, Giwa BM, Berg KM, Roehrich H, Feng X, Olsen TW, Ferrington DA. Retinal Proteins Modified by 4-Hydroxynononeal: Identification of Molecular Targets. Exp Eye Res 83 (1), pp 165-175; July 2006.

45. Nordgaard CL, Berg, KM, Kapphahn RJ, Reilly C, Feng X, Olsen TW, Ferrington DA. Proteomics of the Retinal Pigment Epithelium Reveals Altered Protein Expression at Progressive Stages of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 47 (3): 815-822, March 2006.

46. Aizman A, Johnson MW, Olsen TW, Ho AC, Davis JL. Diagnostic and Therapeutic

Challenges. Ed by McDonald HR. Retina 26:3: pp 345-351, March 2006.

47. Feng X, Pilon K, Yaacobi Y, Olsen TW*. Extraocular Muscle Insertion Relative to the Fovea and Optic Nerve: Humans and Rhesus Macaque. Invest Ophthalmol Vis Sci. 46(10): 3493-3496, October 2005.

48. Olsen TW*. Measurements Biomarkers and Interpretation. Editorial by Invitation. Am J. Ophthalmol, 139 (4): 710-11, April 2005.

49. Ethen CM, Feng X, Olsen TW, Ferrington DA. Declines in Arrestin and Rhodopsin in the Macula with Progression of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 46 (3): 769-775, March 2005.

50. Simon J, Sood S, Yoon MK, Kaw P, Zobal-Ratner J, Archer S, Gardiner JA, Hutchinson A, Marcotty A, Noel LP, Olsen TW, Tawansy K, Wallace D. Vitrectomy for Dense Vitreous Hemorrhage in Infancy. J Ped Ophthalmol and Strab 42(1): 18-22. January/February

2005.

51. Olsen TW* and Feng X. The Minnesota Grading System of Eyebank Eyes for Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 45 (12): 4484-4490, December 2004.

52. Olsen TW*. Book Review: Retina and Optic Nerve Imaging. Ciulla TA, Regillo CD, and Haris A. editors. Arch Ophththalmol; 122(7); 1095, July 2004.

53. Wu CW, Sauter JL, Johnson PK, Chen C, Olsen TW*. Identification and Localization of Major Soluble Vitreous Proteins in Human Ocular Tissue. Am J Ophthalmol 137:4;655-61, April, 2004.

54. Telander DG, Pambuccian SE, Olsen TW*. Systemic Aspergillus Presenting With Visual Symptoms. Retina 24:1; 166-168, 2004.

55. Olsen TW*, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluorescein Angiographic Lesion Type Frequency in Neovascular Age-Related Macular Degeneration Ophthalmology 111:2; 250-255, 2004.

56. Malik KJ, Chen CD, Olsen TW*. Stability of RNA from the Retina and Retinal Pigment Epithelium in a Porcine Model Simulating Human Eye-Bank Conditions. Invest Ophthalmol Vis Sci. 44 (6): 2730-5, 2003.

57. Olsen TW*, Sanderson S, Feng X, Hubbard WC. Porcine Sclera: Thickness and Surface Area. Invest Ophthalmol Vis Sci. 43 (8): 2529-32, 2002.

58. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of Submacular Hemorrhage with Low-Dose Intravitreal Tissue Plasminogen Activator Injection and Pneumatic Displacement. Arch Ophthalmol 119:28-32, 2001.

59. Beecher DJ, Olsen TW, Somers EB, Wong ACL. Evidence for Contribution of Tripartite Hemolysin BL, Phasphatidylcholine-Preferring Phospholipase C, and Collagenase to Virulence of Bacillus cereus Endophthalmitis. Infection & Immunity 68:9, 5269-5276, September 2000.

60. Olsen TW, Sternberg P, Capone A, Martin DF, Lim JI, Grossniklaus HE, Aaberg TM. Macular Hole Surgery Using Thrombin Activated Fibrinogen and Selective Removal of the Internal Limiting Membrane. [Letter], Retina 19:5; 478-479, 1999.

61. Olsen TW*, Frayer WC, Myers FL, Davis MD, Albert DM. Idiopathic Reactive Hyperplasia of the Retinal Pigment Epithelium. Arch Ophthalmol 117:50-54, Jan 1999.

62. Olsen TW*: Book Review: Laser Surgery of the Posterior Segment. Bloom SM, Brucker AJ. Arch Ophthalmol; 116 (3); 403, 1998.

63. Olsen TW, Sternberg P, Capone A, Martin DF, Lim JI, Grossniklaus HE, Aaberg TM. Macular Hole Surgery Using Thrombin Activated Fibrinogen and Selective Removal of the Internal Limiting Membrane. Retina 18:4; 322-329, 1998.

64. Olsen TW*, Aaberg SY, Geroski DH, Edelhauser HF. Human Sclera: Thickness and Surface Area. Am J Ophthalmol 125:237-241, February 1998.

65. Olsen TW*, Summers CG. Predicting Visual Acuity in Eyes with Fundus Colobomas: Optic Nerve Involvement, Size, or the Fovea? (Letter) Ophthalmology 104; 1367-1368, 1997.

66. Olsen TW*. Visual Acuity in Children with Colobomatous Defects. Current Opinion in

Ophthalmology; 8:III; 63-67, August 1997.

67. Pieramici DJ, Sternberg P, Aaberg TM, Bridges WZ, Capone A, Cardillo JA, DeJuan E, Kuhn F, Meredith TA, Mieler WF, Olsen TW, Rubsamen P, Stout T (The Ocular Trauma Classification Group). A System for Classifying Mechanical Injuries of the Eye (Globe). Am J Ophthalmol 123; 820-831, June 1997.

68. Olsen TW*. Submacular Surgery for Age-Related Macular Degeneration. Seminars of Ophthalmology 12 (1); 34-44, March 1997.

69. Olsen TW, Sternberg P Jr., Reed R, Jones DP. A Model for Light Toxicity of Cultured Human Retinal Pigment Epithelium. Graefes Archive for Clinical & Experimental Ophthalmology 235; 111-117, 1997.

70. Olsen TW, Capone A Jr., Sternberg P Jr., Grossniklaus HE, Martin DF, Aaberg TM Sr.

Subfoveal Choroidal Neovascular Membranes in Punctate Inner Choroidopathy: Surgical Management and Pathologic Findings. Ophthalmology 103; 2061-2069, 1996.

71. Olsen TW*, Lim JI, Grossniklaus HE. Retained Lens Material Masquerading as a Growing Pigmented Iris Tumor. Arch Ophthalmol 114; 1154-55, 1996. (Cover Photograph of the September issue used from this Article).

72. Olsen TW, Sternberg P Jr., Martin DF, Capone A, Lim JI, Aaberg TM Sr. Postoperative Hypopyon after Intravitreal Bovine Thrombin for Macular Hole Surgery. Am J Ophthalmol 121; 575-577, 1996.

73. Olsen TW, Summers CG, Knobloch W. Predicting Visual Acuity in Children with Colobomas Involving the Optic Nerve Colobomas. J Pediatric Ophthalmol Strabismus 33; 47-51, 1996.

74. Olsen TW, Gothard TW, Holland EJ. Misoprostol and Cyclosporin A Prolong Corneal Allograft Survival in an Animal Model. Cornea 15(1); 76-81, 1996.

75. Olsen TW*, Lim JI, Capone A, Myles RA, Gilman JP. Anaphylactic Shock Following Indocyanine Green Angiography. Arch Ophthalmol 114; 97, 1996.

76. Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human Scleral Permeability: Effects of Age, Cryotherapy, Transscleral Diode Laser, and Surgical Thinning. Invest Ophthalmol Vis Sci. 36 (9); 1893-1903, August 1995.

77. Olsen TW Chang TS, Sternberg P, Jr. Retinal Detachments Associated with Blunt Trauma. Seminars in Ophthalmology 10 (1); 17-27, March 1995.

78. Olsen TW, Benegas NM, Joplin AC, Evangelista A, Mindrup EA, Holland EJ. Rapamycin Inhibits Corneal Allograft Rejection and Neovascularization. Arch Ophthalmol 112; 1471-1475, 1994. Published erratum, 113:144, 1995.

79. Holland EJ, Olsen TW, Chan CC, Bergstrom L, Palestine AG, Nussenblatt RB. Kinetics of Corneal Transplant Rejection in the Rat Penetrating Keratoplasty Model. Cornea 13(4); 317-323, 1994.

80. Olsen TW, Hardten DR, Meiusi RS, Holland EJ. Linear Endotheliitis. Am J Ophthalmol 117; 468-474, 1994.

81. Holland EJ, Olsen TW, Sterrer J, Ketchum JM, Mindrup EA, Gruber SA. Suppression of

Graft Rejection using 15-Deoxyspergualin in the Allogeneic Rat Penetrating Keratoplasty

Model. Cornea 13(1); 28-32, 1994.

82. Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ, Lam S, Tessler

HH, Sugar J. Topical Cyclosporin A in the Treatment of Anterior Segment Inflammatory Disease. Cornea 12(5); 413-419, 1993.

SELECTED COLLABORATIVE STUDY PUBLICATIONS

1. Writing Group for the ARG, Bonds DE, Harrington M, et al. Effect of Long-Chain omega-3 Fatty Acids and Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial. JAMA internal medicine. Mar 17 2014.

2. Birch DG, Weleber RG, Duncan JL, Jaffe GJ, Tao W, Ciliary Neurotrophic Factor Retinitis Pigmentosa Study G. Randomized Trial of Ciliary Neurotrophic Factor Delivered by Encapsulated Cell Intraocular Implants for Retinitis Pigmentosa. Am J Ophthalmol. May 10 2013.

3. Age-Related Eye Disease Study 2 Research G. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2

(AREDS2) randomized clinical trial. JAMA. May 15 2013;309(19):2005-2015.

4. Chew EY, Clemons TE, Agron E, et al. Long-Term Effects of Vitamins C and E, beta-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35. Ophthalmology. Apr 10 2013.

5. Chew EY, Clemons T, Sangiovanni JP, et al. The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1). Ophthalmology 2012.

6. CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. NEJM 364(20):1897-1908; 2011.

7. Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA, Qin H,

Apte RS, Beck RR, Bressler NM, Browning DJ, Danis RP, Glassman AR, Googe JM, Kollman C, Lauer AK, Peters MA, Stockman ME. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010 Jun; 117 (6) :1087-1093.e3. PubMed PMID:20299105; PubMed Central PMCID: PMC2911350.

8. Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL 3rd, Klein ML, Armstrong JR; Age-Related Eye Disease Study Research Group. Change in area of geographic atrophy in

the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. Sep;127(9):1168-74. 2009.

9. Beck RW, Edwards AR, Aiello LP, et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009;127:245-51.

10. Lindblad AS, Lloyd PC, Clemons TE, Gensler GR, Ferris FL 3rd, Klein ML, Armstrong JR,

Age-Related Eye Disease Study Research Group. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol. 2009 Sep; 127 (9):1168-74. PubMed PMID:19752426.

11. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008 Sep; 115 (9) :1447-9, 1449.e1-10. PubMed

PMID:18662829; PubMed Central PMCID: PMC2748264.

12. The DCCT/EDIC Study Research Group. Long-term Effect of Diabetes and Its Treatment on Cognitive Function. New England Journal of Medicine. 2007;356;18:1842-52.

13. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27. Ophthalmology 2007;114:1363-71.

14. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. DRCRnet, Ophthalmology March 2007;114:3:525-536.

15. Fong DS, Strauber SF, Aiello LP, et al. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol 2007;125:469-80.

16. Anecortave Acetate (15 Milligrams) versus Photodynamic Therap for Treatment of Subfoveal Neovascularization in Age-Related Macular Degeneration. Slakter JS, Bochow T, D’Amico DJ, et al. and the Anecortave Acetate Clinical Study Group. Ophthalmology 2006;113:3-13 pp 3-13.

17. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol

2006;124:1684-93.

18. 15-Year Outcomes Following Threshold Retinopathy of Prematurity: Final Results From the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 2005;123:311-318.

19. Clemons TE, Kurinij N, Sperduto RD. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 2004;122:716-726.

20. Trends in size and treatment of recently diagnosed choroidal melanoma, 1987-1997: findings from patients examined at collaborative ocular melanoma study (COMS) centers: COMS report no. 20. Arch Ophthalmol 2003;121:1156-62.

21. Comparison of clinical, echographic, and histopathological measurements from eyes with medium-sized choroidal melanoma in the collaborative ocular melanoma study: COMS report no. 21. Arch Ophthalmol 2003;121:1163-71.

22. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439-1452.

23. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436.

24. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000;105:295-310.

AAO Monographs

1. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L. Age-

Related Macular Degeneration; Retina Preferred Practice Patterns ®; American Academy of Ophthalmology ®, 2014.

2. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L. Diabetic

Retinopathy; Retina Preferred Practice Patterns ®; American Academy of Ophthalmology ®, 2014.

3. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L. Idiopathic Macular Hole; Retina Preferred Practice Patterns ®; American Academy of Ophthalmology ®, 2014.

4. Olsen, TW, Adelman RA, Flaxel CJ, Folk JC, Pulido JS, Regillo CD, Hyman L. Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration; Retina

Preferred Practice Patterns ®; American Academy of Ophthalmology ®, 2014. 5. Olsen, TW, Sippy BD, Atebara NH, Gottlieb JL, Hasan SJ, Solley WA, Suner IJ.

Practicing Ophthalmologists Curriculum (POC) Learning System. Retina/Vitreous © American Academy of Ophthalmology; 2014-2016

BOOK CHAPTERS (n=25; ** winner of the British Medical Association Medical Book Award 2016)

1. ** Yamada N, Olsen TW: Routes for Drug Delivery to the Retina: Topical, Transscleral,

Suprachoroidal, and Intravitreal Gas-Phase Nanoparticles. Retinal Pharmacotherapeutics. Animal Models and Routes for Retinal Drug Delivery. Ed: Quan Dong Nyguyen, Eduardo B. Rodreiques, Michael Farah, William F. Mieler, and Diana V Do. Dev Ophthalmol. Basel, Karger, vol 55 pp 71-83, DOI: 10.1159/000431193 in 2016.

2. Payne JF, Hubbard GB, Olsen TW: General Considerations in Opthalmic Surgery. Section 23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of

Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 693-695, 2013.

3. Shah R, Kim JY, Olsen TW: Cataract Surgery. Section 23 Ophthalmic Surgery in Medical

Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 696-697, 2013.

4. McKee Y, Shah R, Kim JY, Olsen TW: Corneal Transplantation. Section 23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 698-700, 2013.

5. Rahman HT, Hubbard GB, Olsen TW: Vitreoretinal Surgery. Section 23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 700-702, 2013.

6. Germain BB, Costarides AP, Olsen TW: Glaucoma Surgery. Section 23 Ophthalmic

Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 702-704, 2013.

7. Shah R, McKee Y, Randleman JB, Olsen TW: Refractive Surgery. Section 23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 704-706, 2013.

8. Couser NL, Hutchinson AK, Olsen TW: Strabismus Surgery. Section 23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 706-708, 2013.

9. Wells JR, Hubbard GB, Olsen TW: Enucleation, Evisceration, and Exenteration. Section

23 Ophthalmic Surgery in Medical Management of the Surgical Patient, A Texbook of Perioperative Medicine, 5th Edition, Editors Lubin MF, Dodson TF, Winawer NH; Cambridge University Press; pp 708-710, 2013.

10. Olsen TW: Trauma, in: Clinical Retina. Second Edition, Edited by David A. Quillen and Barbara Blodi, AMA press, USA (In Press).

11. Olsen TW, Sippy BD, Atebara NH, Gottlieb JL, Hasan SJ, Solley WA, Suner IJ. Practicing Opthalmololgists Curriculum: Retina/Vitreous 2011-2013. Academy MOC Essentials. American Academy of Ophthalmology; pp 1-241, 2011. (Book Author)

12. Olsen TW and Gilger BC Suprachoroidal and Intrascleral Drug Delivery. Chapter 8 in Drug Product Development for the Back of the Eye, AAPS Advances in the Pharmaceutical Sciences Series, American Association of Pharmaceutical Scientists, Springer; pp 173-184, 2011.

13. Charkoudian LD, Olsen TW: Principles and Treatment of Giant Retinal Tears. Section 5; Retinal Surgery, Section Ed Jay S. Duker in Clinical Atlas of Procedures in Ophthalmic Surgery, 2nd Edition (Oxford Ophthalmology Atlas Series), Ed(s) Daniel M. Albert & Mark J. Lucarelli; pp 444-451, 2011.

14. Olsen TW: Routes for Drug Delivery to the Retina: Topical, Transscleral, Suprachoroidal, and Intravitreal Gas-Phase Nanoparticles. Retinal Pharmacotherapy. Editors Quan Dong

Nyguyen, Eduardo B. Rodreiques, Michael Farah, and William F. Mieler. First Edition. Saunders Elsevier Ltd. 2010.

15. Olsen TW: When a Posterior Capsular Tear Occurs During Cataract Surgery, What Next? Chapter 37, in Curbside Consultation in Retina; Ed. Sharon Fekrat, Assoc. Ed Darius Moshfeghi, Dean Elliot, Series Ed David F. Chang, SLACK Inc., New Jersey, USA, 2010.

16. Olsen TW: Retina, (Chapter 10), in: Primary Care Ophthalmology. Edited by Jay H. Krachmer and David Palay, Mosby, St. Louis, MO; 2nd Edition, pp 149-187; 2005.

17. Olsen TW: Principles of Giant Retinal Tears and Treatment. Section 4: Retina and Vitreous Surgery, Section editor, Justin L. Gottlieb, in Clinical Atlas of Procedures in Ophthalmic Surgery. Edited by Daniel M. Albert and Mark J. Lucarelli. AMA Press, USA, 2004; pp 142-145.

18. Olsen TW: Scleral Buckling & Pneumatic Retinopexy. Section 4: Retina and Vitreous Surgery, Section editor, Justin L. Gottlieb, in Clinical Atlas of Procedures in Ophthalmic Surgery. Edited by Daniel M. Albert and Mark J. Lucarelli. AMA Press, USA, 2004; pp 122-127.

19. Olsen TW: Trauma, in: Clinical Retina. Edited by David A. Quillen and Barbara Blodi, AMA press, USA, pp 285-300, 2003.

20. Olsen TW, Nork TM: Giant Retinal Tears, in: Ophthalmic Surgery: Principles and Techniques. Edited by Daniel M. Albert and William Mieler, Blackwell, Cambridge, Massachusetts. Volume I, Part III, Ch. 45, pp 594-605, 1999.

21. Olsen TW: Principles of Scleral Buckling & Pneumatic Retinopexy, in: Ophthalmic Surgery: Principles and Techniques. Edited by Daniel M. Albert and William Mieler, Blackwell, Cambridge, Massachusetts. Volume I, Part III, Ch 41, pp 511-530, 1999.

22. Kurtz JC, Jones DP, Sternberg P, Wei MW, Olsen TW: Antioxidant functions of glutathione in human retinal pigment epithelium in relation to age-related macular degeneration. In Piccolino FC, Coscas G (eds.) Retinal Pigment Epithelium and Macular

Diseases. Kluwer Academic Publishers, 1998, pp. 47-58.

23. Olsen TW: Common Retinal Disorders, in: Ophthalmology for the Primary Care Physician. Edited by Jay H. Krachmer and David Palay, Mosby, St. Louis, MO; Ch 9, pp

102-134, 1997.

24. Watsky MA, Olsen TW, and Edelhauser HF: Cornea and Sclera, in: Duane’s Foundations of Clinical Ophthalmology. Edited by William Tasman and Edward A. Jaeger, Lippincott-Raven, Philadelphia-New York; Vol 2, Ch 4, pp 1-29, 1995.

25. Holland EJ, Olsen TW: Immunosuppression in High Risk Corneal Transplantation, in: Corneal Surgery, Theory, Technique, and Tissue. Edited by Fredrick S. Brightbill, Mosby,

pp 260-268, 1993.

NON-PEER REVIEWED PUBLICATIONS, COMMENTARY, OPINION 1. Olsen, TW: Drug Delivery to the Retina, Questions, Thoughts, and Opinions Related to

Current and Emerging Drug Delivery Systems: Special Focus Drug Delivery, September

Issue, 2016.

2. Olsen TW, Adelman RA, Brown D, Charles S, Mieler W, Boyer D, Warren K. Retina Clinical Committee responds to “Pearls for YAG vitreolysis of Floaters”. Eye World, Retina Corner, pp 113. March 2015.

3. Study Finds Strong Correlation Between Chorioretinal Folds, Systemic Disease.

Commentary by Bob Bronemyer, Ocular Surgery News. August 25, 2014.

4. Tornambe PE, Singer M, Olsen TW, London N. In cases of symptomatic vitreomacular adhesion without full-thickness macular hole, do you tend to observe for spontaneous

resolution or treat with Jetrea (ocriplasmin, Thromobogenetics)? Ocular Surgery News, Survey of 150+ Leading Retina Specialists. October 24, 2013, pp 57.

5. Olsen TW, Stewart JM, ed Chang DF. AMD Info Every Anterior Segment Specialist

Should Know. EyeWorld; October 2013; pp 104-106.

6. Olsen TW. 8 questions with Dr. Puliafito. Ophthalmic Surg Lasers Imaging Retina 2013;44(4):424-5.

7. Olsen TW (commentary): “Do you already recommend a supplement formulation that includes lutein and Zeaxanthin in patients with macular degeneration?” and “Do you or would you recommend . . . omega-3 . . for AMD . . .?” Ocular Surgery News Survey of

150+ Leading Retina Specialists (Chosen as the lead commentary: July 25, 2013 pp 28.

8. Singer MA, Olsen TW, Lim JI, and Fine HF: Ocular Surgery News Survey of 150+ Leading Retina Specialists (Chosen as the lead commentary of 3 opinions in this article: “In your practice, do you diagnose retinal detachments using ultrasound?” March 25, 2013.

9. Singer MA, Olsen TW, Lim JI, and Fine HF: Ocular Surgery News Survey of 150+ Leading Retina Specialists (Chosen as the lead commentary of 3 opinions in this article: “Do you

perform pneumatic retinopexy as first line management for cases of primary retinal detachment?” February 25, 2013.

10. Olsen TW, Lim JI, and Freund KB: Ocular Surgery News Survey of 150+ Leading Retina Specialists, Chosen as the lead commentary of 3 opinions in this article: “Do you perform peripheral fluorescein angiography guided panretinal laser photocoagulation for ischemic retinopathies (e.g. PDR or ischemic CRVO) or do you apply scatter laser in another way?”

October 25, 2012.

11. Kim T, Olsen TW. Cataract Experts Share Their Surgical Mishaps. Case #13: It’s going, going, gone . . . or maybe not. EYENET (AAO news publication). February 2012 pp 44-62.

12. Kaiser RS, Olsen TW, Freund KB, Gottlieb JL, Suner IJ; Spirin MJ & Regillo CD (eds): Key Opinion Leaders Comment on: Diagnosis and Management of Retinal Vein Occlusions.

Retina Times, Spring 2009 pp 21-26.

13. Olsen TW, Hartnett ME: Consultants for Focal Points (Clinical Modules for Ophthalmologists); Pharmacotherapy Targeting Ocular Neovascularization (Comments to issues raised in the Review). American Academy of Ophthalmology; Volume XXVI, 7, September 2008.

14. Olsen TW: Drug Delivery to the Retina Using Intravitreal Aerosolized Nanoparticles. Retina Physician, June, 2008, pp 26-32, 2008.

15. Olsen TW: Drug Delivery to the Suprachoroidal Space Shows Promise: Retina Today, March/April 2007; pp 36-39.

16. Klesert TR, Section ed. Chang T, Ed.; Bovino JA, Harbour JW, Heier J, Olsen TW, Pieramici D, Postel E, Schachat A, Shah GK. What is the Future for Academic Retina Programs? Part 1. Key Opinion Leaders, Retina Times, Fall 2006, pp 22-27.

17. Bressler NM, Klein ML, MacCumber MW, Mieler WF, Olsen TW. Case Studies: Current and Future Treatment Options for Neovascular Age-Related Macular Degeneration. Advanced Studies in Ophthalmology 2:3; December 2005 pp 113-120.

18. Cunningham ET, Arroyo JG, Olsen TW, Regillo CD, Slakter JS. Round Table: Clinicans Explore the latest results, outlook for photodynamic Therapy. Ocular Surgery News,

January 15, 2003.

19. Olsen TW, Lim JI, Grossniklaus HE. Material Cristalino Retenido Que Semeja Un Tumor Pigment Ado En Crecimiento Del Iris. Arch Ophthalmol Edición Española 8; 29-30, 1997.

20. Olsen TW, Lim JI, Capone A, Myles RA, Gilman JP. Choque anafiláctico tras angiografía con verde de indocianina. Arch Ophthalmol Edición Española 7; 149-50, 1996.

21. Olsen TW, Benegas NM, Joplin AC, Evangelista A, Mindrup EA, Holland EJ. La Rapamicina Inhibe El Rechazo Y La Neovascularización De Los Aloinjertos Corneales. Arch Ophthalmol Edición Española 6; 68-72, 1995.